Erratum to Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage (Int J Nanomedicine, (2013), 8, (1451–1462) 10.2147/IJN.S26364);Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1451-1462

  Srivastava, Amit Kumar ^a   Bhatnagar, Priyanka ^b   Singh, Madhulika ^a   Mishra, Sanjay ^a   Kumar, Pradeep ^b   Shukla, Yogeshwer ^a   Gupta, Kailash Chand ^a,b  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

DNA alkaline unwinding assay; DNA repair; Mouse skin

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLOOXYGENASE 2; EPIGALLOCATECHIN GALLATE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; NANOPARTICLE; POLYGLACTIN; PROTEIN MDM2; PROTEIN P21; THEAFLAVIN; XRCC1 PROTEIN; XRCC3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COX 2 GENE; DNA DAMAGE; DNA REPAIR; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG FORMULATION; ENCAPSULATION; ERCC3 GENE; GADD45ALPHA GENE; GENE; GENE INDUCTION; MDM2 GENE; MOUSE; NONHUMAN; P21 GENE; SKIN; SKIN PROTECTION; SYNTHESIS; TEA; TUMOR SUPPRESSOR GENE; XRCC1 GENE; XRCC3 GENE;

EID: 84876275049     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S226028     Document Type: Erratum

References (44)

1. Siomi H. Transposable elements, RNA silencing, and their impacts on the genome throughout evolution. Uirusu. 2008;58(1):55-60.
2. Triampoa W, Triampob D, Ming Tangb I, Lenburyc Y. The stochastic model of non-equilibrium mutagen-induced alterations of DNA: Implication to genetic instability in cancer. Biosystems. 2007;90(3): 870-880.
3. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992;21(3):334-350.
4. Weisburger JH. Tea and health: a historical perspective. Cancer Lett. 1997;114(1-2):315-317.
5. McKay DL, Blumberg JB. The role of tea in human health: an update. J Am Coll Nutr. 2002;21(1):1-13.
6. Leone M, Zhai D, Sareth S, Kitada S, Reed JC, Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct Inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 2003;63(23):8118-8121.
7. Ahmad N, Mukhtar H. Green tea polyphenols and cancer: biological mechanisms and practical implications. Nutr Rev. 1999;57(3):78-83.
8. Yang CS, Maliaka P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol. 2002;42(1):25-54.
9. Choudhury SR, Balasubramanian S, Chew YC, Han B, Marquez VE, Eckert RL. (-)-Epigallocathechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells. Carcinogenesis. 2011;32(10):1525-1532.
10. Patel R, Krishnan R, Ramchandani A, Maru G. Polymeric black tea polyphenols inhibit mouse skin chemical carcinogenesis by decreasing cell proliferation. Cell Prolif. 2008;41(3):532-553.
11. Roy P, George J, Srivastava S, Tyagi S, Shukla Y. Inhibitory effects of tea polyphenols by targeting cyclooxygenase-2 through regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumors. Invest New Drugs. 2011;29(2):225-231.
12. Prasad S, Kaur J, Roy P, Kalra N, Shukla Y. Theaflavins induce G2/M arrest by modulating expression of p21waf1/cip1, cdc25C and cyclin B in human prostate carcinoma PC-3 cells. Life Sci. 2007;81(17-18):1323-1331.
13. Siddiqui IA, Afaq F, Adhami VM, Mukhtar H. Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Chem Biol Interact. 2008;171(2):122-132.
14. Nishiyama N. Nanomedicine: nanocarriers shape up for long life. Nat Nanotechnol. 2007;2(4):203-204.
15. Demming A. Big challenges and nanosolutions. Nanotechnology. 2011;22(29):290201.
16. Hu S, Zhang Y. Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation. Int J Nanomedicine. 2010;24:5:1039-1048.
17. Yallapu MM, Gupta BK, Jaggi M, Chauhan SC. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci. 2010;351(1):19-29.
18. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials. 2000;21(23):2475-2490.
19. Green A, Whiteman D, Frost C, Battistutta D. Sun exposure, skin cancers and related skin conditions. J Epidemiol. 1999;9(6 Suppl):S7-S13.
20. Gupta S, Mukhtar H. Chemoprevention of skin cancer through natural agents. Skin Pharmacol. Appl Skin Physiol. 2001;14(6):373-385.
21. Rockley PF, Trieff N, Wagner Jr RF, Tyring SK. Nonsunlight risk factors for malignant melanoma. Part I: chemical agents, physical conditions, and occupation. Int J Dermatol. 1994;33(6):398-406.
22. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2008. CA Cancer J Clin. 2008;58(2):71-96.
23. Murray CJL, Lopez AD. The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge: Harvard University Press; 1996.
24. Lyle BJ, Mares-Perlman JA, Klein BE, Klein R, Greger JL. Supplement users differ from nonusers in demographic, lifestyle, dietary and health characteristics. J Nutr. 1998;128(12):2355-2362.
25. Esmaeili F, Hosseini-Nasr M, Rad-Malekshahi M, Samadi N, Atyabi F, Dinarvand R. Preparation and antibacterial activity of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Nanomedicine. 2007;3(2):161-167.
26. Swami A, Aggarwal A, Pathak A, Patnaik S, Kumar P, Gupta KC. Imidazolyl-PEI modified nanoparticles for enhanced gene delivery. Int J Pharm. 2007;335(1-2):180-192.
27. Khan TH, Prasad L, Anuradha, Sultana S. Soy isoflavones inhibits the genotoxicity of benzo(a)pyrene in Swiss albino mice. Hum Exp Toxicol. 2005;24(3):149-155.
28. Nigam N, Prasad S, Shukla Y. Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin. Food Chem Toxicol. 2007;45(11):2331-2335.
29. Arora A, Siddiqui IA, Shukla Y. Modulation of p53 in 7,12-dimethylbenz[a]anthracene induced skin tumors by diallyl sulphide in Swiss albino mice. Mol Cancer Ther. 2004;3(11):1459-1466.
30. Gopferich A. Mechanisms of polymer degradation and erosion. Biomaterials. 1996;17(2):103-114.
31. Vert M, Li S, Garreau H. More about degradation of LA/GA derived matrices in aqueous media. J Cont Rel. 1991;16(1-2):15-26.
32. Allémann E, Gurny R, Doelker E. Drug-loaded nanoparticles-preparation methods and drug targeting issues. J Pharm Biopharm. 1993;39(5):173-191.
33. Barichello JM, Morishita M, Takayama K, Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm. 1999;25(4):471-476.
34. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release. 1999;57(2):171-185.
35. Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release. 2001;71(1):53-69.
36. Siddiqui IA, Adhami VM, Bharali DJ, et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res. 2009;69(5):1712-1716.
37. Hreljac I, Zajc I, Lah T, Filipi M. Effects of model organophosphorous pesticides on DNA damage and proliferation of HepG2 cells. Environ Mol Mutagen. 2008;49(5):360-367.
38. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408(6810):307-310.
39. Wang S, El-Deiry WS. p73 or p53 regulates human p53 transcription to maintain cell cycle checkpoints. Cancer Res. 2006;66(14):6982-6989.
40. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1 a potential mediator of p53 tumor suppression. Cell. 1993;75(4):817-825.
41. Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW, Fornace AJ Jr. Analysis of the mammalian gadd45 gene and its response to DNA damage. J Biol Chem. 1993;268(32):24385-24393.
42. Liu H, Xiao J, Yang Y, et al. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer. Microvasc Res. 2011;82(2):131-140.
43. Wang A, Wolf DC, Sen B, et al. Dimethylarsinic acid in drinking water changed the morphology of urinary bladder but not the expression of DNA repair genes of bladder transitional epithelium in F344 rats. Toxicol Pathol. 2009;37(4):425-437.
44. Srivastava S, Verma M, Henson DE. Biomarkers for early detection of colon cancer. Clinical Cancer Res. 2001;7(5):1118-1126.